These results are consistent with the study in a non-small cell lung cancer model which showed that overexpression of TIMP-2 upregulated E-Cad expression in in vitro and in vivo models, contributing to the maintenance of cell-cell adhesion and inhibition of tumour growth [44, 51]. Here, TIMP2 is linked to non-small cell lung carcinoma.